Are Covid Shots Fueling More Dangerous Mutations?
Will mass injections against COVID-19 encourage the mutation of more dangerous versions of SARS-CoV-2? In the video above, WhatsHerFace questions why the U.K. government is procuring 6 million pounds’ worth of body bags, or “temporary body storage,” even as government officials announce that the current vaccination rate has “created a protective wall” against the infection.1
If that’s true, why are they expecting an “excess death scenario” requiring massive numbers of body bags? The procurement agreement will remain in effect for a period of four years. Does the U.K. government know something they’re not sharing with the public?
Have they peeked at the actual science and realized that mass vaccination during an active pandemic might encourage mutations that evade vaccine-induced defenses, or that the gene-modifying injections might render the vaccinated more susceptible to serious illness and death through a mechanism known as antibody-dependent enhancement (ADE) or the more descriptive term, paradoxical immune enhancement (PIE)?
Where Are the Variants Coming From, and Why Now?
WhatsHerFace highlights some of the answers given by health professionals on social media when asked why no problematic variants emerged during the first year, when no COVID injections were available, and only popped up after the mass injection campaign started.
According to one such answer, “Our surveillance sucked in the beginning and it takes time for variants to come about but once they come they become rampant.” Interestingly, as noted in a February 15, 2021, article in The Conversation,2 variants with “measurably different behavior” did not emerge until mid-December 2020, which just so happens to be the exact time at which the first COVID shots were rolled out.
Fact checkers have tried to debunk any connection between COVID shot rollouts and the emergence of variants by showing that variants were identified in various areas before the shots were introduced in those same regions. However, as noted by WhatsHerFace, vaccine makers were conducting large-scale trials in those areas well before the shots became available to the public.
For example, Pfizer enrolled more than 46,000 participants in the U.S., Argentina, Brazil, South Africa, Germany and Turkey,3 and Oxford/AstraZeneca injected 23,000 participants in the U.K., Brazil and South Africa.
“Now this is very interesting,” WhatsHerFace says, “because you’ll actually find that each of the areas where variants first emerged just happen to be the same countries where the trials took place.”
The Backstory of the Delta Variant
The Delta variant (B.1.617.2) was initially identified in India December 1 and 11, 2020. While the COVID jabs were not rolled out in India until mid-January 2021, Phase 3 trials for Biotech’s Covaxin were initiated in Bharat, India, November 16, 2020. By December 22, 2020, 22,500 volunteers had received the jab.
On a side note, the Indian government released Covaxin to the public before Phase 3 trials were completed and in the absence of any safety or efficacy data. According to some vaccinologists, the emergence of potentially more problematic variants following mass vaccination rollouts during an active pandemic is precisely what you’d expect.
Dr. Geert Vanden Bosche,4 whose resume includes work with GSK Biologicals, Novartis Vaccines, Solvay Biologicals and the Bill & Melinda Gates Foundation, published an open letter5 to the World Health Organization, March 6, 2021.
In the letter, Bosche warned that implementing a global mass vaccination campaign during the height of the pandemic could create an “uncontrollable monster” where evolutionary pressure will force the emergence of new and potentially more dangerous mutations.
“There can be no doubt that continued mass vaccination campaigns will enable new, more infectious viral variants to become increasingly dominant and ultimately result in a dramatic incline in new cases despite enhanced vaccine coverage rates. There can be no doubt either that this situation will soon lead to complete resistance of circulating variants to the current vaccines,” Bossche wrote.6
‘Leaky’ Vaccines Promote Mutations
In short, when vaccines that don’t provide robust immunity are overused, they allow viruses to mutate in potentially hazardous ways. When you overuse an antibiotic that fails to eradicate the bacteria, antibiotic-resistant bacteria are allowed to flourish.
In the same way, overuse of a vaccine that doesn’t provide immunity can allow the virus to mutate inside vaccinated individuals into variants that evade vaccine-induced immunity.
And, as we already know, the COVID shots do not prevent infection or transmission, hence the variants created inside vaccinated individuals will spread, attacking both vaccinated and unvaccinated alike. This hypothesis was confirmed in a 2015 study7 in PLOS Biology, which found that “imperfect vaccination can enhance the transmission of highly virulent pathogens.” As explained by the authors:8
“There is a theoretical expectation that some types of vaccines could prompt the evolution of more virulent (‘hotter’) pathogens. This idea follows from the notion that natural selection removes pathogen strains that are so ‘hot’ that they kill their hosts and, therefore, themselves.
Vaccines that let the hosts survive but do not prevent the spread of the pathogen relax this selection, allowing the evolution of hotter pathogens to occur. This type of vaccine is often called a leaky vaccine. When vaccines prevent transmission, as is the case for nearly all vaccines used in humans, this type of evolution towards increased virulence is blocked.
But when vaccines leak, allowing at least some pathogen transmission, they could create the ecological conditions that would allow hot strains to emerge and persist.
This theory proved highly controversial when it was first proposed over a decade ago, but here we report experiments with Marek’s disease virus in poultry that show that modern commercial leaky vaccines can have precisely this effect: they allow the onward transmission of strains otherwise too lethal to persist.
Thus, the use of leaky vaccines can facilitate the evolution of pathogen strains that put unvaccinated hosts at greater risk of severe disease.”
This research was reported in a number of mainstream media publications, including Live Science,9 Newsweek10 and National Geographic.11 Quanta Magazine also took a deep dive into it in May 2018, closing the article with the following observation:12
“… the most crucial need right
Article from LewRockwell